{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:09:44Z","timestamp":1783098584147,"version":"3.54.6"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-13-301-01"],"award-info":[{"award-number":["RSG-13-301-01"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR068332"],"award-info":[{"award-number":["R01 AR068332"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00335","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T04:15:35Z","timestamp":1529295335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment"],"prefix":"10.3389","volume":"9","author":[{"given":"Ushashi C.","family":"Dadwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B3","volume-title":"SEER Cancer Statistics Review, 1975\u20132015","author":"Noone","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jnci\/djh235","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"B6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/pcan.2016.62","article-title":"Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials","volume":"20","author":"Saad","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/bonekey.2015.85","article-title":"Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review","volume":"4","author":"Bienz","year":"2015","journal-title":"Bonekey Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/00005392-200209000-00024","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75646","DOI":"10.18632\/oncotarget.17980","article-title":"The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation","volume":"8","author":"Cianferotti","year":"2017","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajur.2015.10.003","article-title":"Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-na\u00efve metastatic prostate cancer patients \u2013 a propensity scoring approach","volume":"3","author":"Nagao","year":"2016","journal-title":"Asian J Urol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","article-title":"Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance","volume":"164","author":"Holzbeierlein","year":"2004","journal-title":"Am J Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10555-017-9719-4","article-title":"Current perspectives on bone metastases in castrate-resistant prostate cancer","volume":"37","author":"Logothetis","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.juro.2017.08.103","article-title":"Long-term antitumor activity and safety of enzalutamide monotherapy in hormone naive prostate cancer: 3-year open label followup results","volume":"199","author":"Tombal","year":"2018","journal-title":"J Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast","volume":"1","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/ijc.26024","article-title":"Steps in prostate cancer progression that lead to bone metastasis","volume":"128","author":"Jin","year":"2011","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00223-017-0350-8","article-title":"Bone marrow microenvironment as a regulator and therapeutic target for prostate cancer bone metastasis","volume":"102","author":"Park","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B19","first-page":"27","article-title":"Wnt signaling in castration-resistant prostate cancer: implications for therapy","volume":"2","author":"Yokoyama","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"key":"B22","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.3390\/ijms140714240","article-title":"Intercellular communication by exosome-derived microRNAs in cancer","volume":"14","author":"Hannafon","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"94834","DOI":"10.18632\/oncotarget.22014","article-title":"Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2174\/1389450116666150325231419","article-title":"A comprehensive review on miR-200c, a promising cancer biomarker with therapeutic potential","volume":"16","author":"Kumar","year":"2015","journal-title":"Curr Drug Targets"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1158\/1541-7786.MCR-08-0077","article-title":"Cadherin-11 promotes the metastasis of prostate cancer cells to bone","volume":"6","author":"Chu","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1158\/1541-7786.MCR-13-0108","article-title":"Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis","volume":"11","author":"Lee","year":"2013","journal-title":"Mol Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44824","DOI":"10.1038\/srep44824","article-title":"Alteration of osteoblast arrangement via direct attack by cancer cells: new insights into bone metastasis","volume":"7","author":"Kimura","year":"2017","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00223-017-0365-1","article-title":"Osteomimicry: how the seed grows in the soil","volume":"102","author":"Rucci","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0736-0266(02)00095-5","article-title":"Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone","volume":"21","author":"Lee","year":"2003","journal-title":"J Orthop Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.devcel.2017.05.015","article-title":"The bony side of endothelial cells in prostate cancer","volume":"41","author":"Peng","year":"2017","journal-title":"Dev Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.devcel.2017.05.005","article-title":"Endothelial-to-osteoblast conversion generates osteoblastic metastasis of prostate cancer","volume":"41","author":"Lin","year":"2017","journal-title":"Dev Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma","volume":"76","author":"Delgado-Calle","year":"2016","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1158\/0008-5472.CAN-14-2493","article-title":"Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases","volume":"75","author":"Sottnik","year":"2015","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1359\/JBMR.041109","article-title":"Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo","volume":"20","author":"Sun","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1158\/0008-5472.CAN-04-0691","article-title":"Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin","volume":"64","author":"Dimitroff","year":"2004","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ncomms2766","article-title":"Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis","volume":"4","author":"Jung","year":"2013","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jnci\/90.12.911","article-title":"Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study","volume":"90","author":"Wolk","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"B40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsbmb.2010.09.003","article-title":"Steroid 5 \u03b1-reductase inhibitors targeting BPH and prostate cancer","volume":"125","author":"Schmidt","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1158\/1078-0432.CCR-08-2262","article-title":"Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases","volume":"15","author":"Chavin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1359\/jbmr.081217","article-title":"Mineralization and bone resorption are regulated by the androgen receptor in male mice","volume":"24","author":"Chiang","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/00000658-194206000-00030","article-title":"Effect of orchiectomy and irradiation on cancer of the prostate","volume":"115","author":"Huggins","year":"1942","journal-title":"Ann Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/FTD.0000000000000484","article-title":"Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: application to clinical management of metastatic castration-resistant prostate cancer patients","volume":"40","author":"Benoist","year":"2018","journal-title":"Ther Drug Monit"},{"key":"B45","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3390\/cancers9010007","article-title":"AR-signaling in human malignancies: prostate cancer and beyond","volume":"9","author":"Schweizer","year":"2017","journal-title":"Cancers (Basel)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/B978-0-323-18907-1.00139-6","article-title":"Chapter 139 \u2013 androgen deficiency disorders A2","volume-title":"Endocrinology: Adult and Pediatric","author":"Allan","year":"2016"},{"key":"B48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsbmb.2010.09.003","article-title":"Steroid 5 \u03b1-reductase inhibitors targeting BPH and prostate cancer","volume":"125","author":"Schmidt","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1242\/jcs.00247","article-title":"The nuclear receptor superfamily","volume":"116","author":"Robinson-Rechavi","year":"2003","journal-title":"J Cell Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/iju.12146","article-title":"Transcriptional network of androgen receptor in prostate cancer progression","volume":"20","author":"Takayama","year":"2013","journal-title":"Int J Urol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jsbmb.2004.10.011","article-title":"Major impact of hormonal therapy in localized prostate cancer \u2013 death can already be an exception","volume":"92","author":"Labrie","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1210\/jc.2003-032058","article-title":"Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.juro.2012.11.016","article-title":"Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer","volume":"189","author":"Smith","year":"2013","journal-title":"J Urol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.juro.2010.06.022","article-title":"Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer","volume":"184","author":"Smith","year":"2010","journal-title":"J Urol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.juro.2011.07.090","article-title":"Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer","volume":"186","author":"Smith","year":"2011","journal-title":"J Urol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/annonc\/mdu519","article-title":"Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events","volume":"26","author":"Smith","year":"2015","journal-title":"Ann Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1702900","article-title":"Abiraterone for prostate cancer not previously treated with hormone therapy","volume":"377","author":"James","year":"2017","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/1078-0432.CCR-16-2955","article-title":"Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models","volume":"23","author":"Suominen","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5489\/cuaj.4415","article-title":"A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: factors associated with treatment completion","volume":"11","author":"Parimi","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1634\/theoncologist.2017-0413","article-title":"Radium-223 safety, efficacy, and concurrent use with abiraterone or enzalutamide: first U.S. experience from an expanded access program","volume":"23","author":"Sartor","year":"2018","journal-title":"Oncologist"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00198-010-1178-5","article-title":"Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture","volume":"21","author":"Huntjens","year":"2010","journal-title":"Osteoporos Int"},{"key":"B62","doi-asserted-by":"publisher","first-page":"26321","DOI":"10.1074\/jbc.M203310200","article-title":"Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor","volume":"277","author":"Masiello","year":"2002","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-11-3948","article-title":"ARN-509: a novel antiandrogen for prostate cancer treatment","volume":"72","author":"Clegg","year":"2012","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2013.50.1684","article-title":"Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer","volume":"31","author":"Rathkopf","year":"2013","journal-title":"J Clin Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12885-016-2702-6","article-title":"Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data","volume":"16","author":"James","year":"2016","journal-title":"BMC Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/15548627.2016.1268300","article-title":"Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression","volume":"13","author":"Blessing","year":"2017","journal-title":"Autophagy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1074\/jbc.M201075200","article-title":"STO-609, a specific inhibitor of the Ca(2+)\/calmodulin-dependent protein kinase kinase","volume":"277","author":"Tokumitsu","year":"2002","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1464-410X.2011.10922.x","article-title":"Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers","volume":"110","author":"Dhani","year":"2012","journal-title":"BJU Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/S1470-2045(17)30450-3","article-title":"Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"18","author":"Kim","year":"2017","journal-title":"Lancet Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1530\/EC-17-0118","article-title":"Clinical relevance of androgen receptor alterations in prostate cancer","volume":"6","author":"Jernberg","year":"2017","journal-title":"Endocr Connect"},{"key":"B72","doi-asserted-by":"publisher","first-page":"64447","DOI":"10.18632\/oncotarget.10901","article-title":"Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer","volume":"7","author":"Wadosky","year":"2016","journal-title":"Oncotarget"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-08-1171","article-title":"Castration-resistant prostate cancer: locking up the molecular escape routes","volume":"15","author":"Attar","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers10010022","article-title":"AR signaling in human malignancies: prostate cancer and beyond","volume":"10","author":"Antonarakis","year":"2018","journal-title":"Cancers"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1158\/1078-0432.CCR-13-1863","article-title":"Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer","volume":"20","author":"Yu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.eururo.2017.01.011","article-title":"Comprehensive profiling of the androgen receptor in liquid biopsies from castration-resistant prostate cancer reveals novel intra-AR structural variation and splice variant expression patterns","volume":"72","author":"De Laere","year":"2017","journal-title":"Eur Urol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"H\u00f6rnberg","year":"2011","journal-title":"PLoS One"},{"key":"B79","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","article-title":"Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1210\/en.2004-0311","article-title":"Identification and validation of novel androgen-regulated genes in prostate cancer","volume":"145","author":"Velasco","year":"2004","journal-title":"Endocrinology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.embor.7401046","article-title":"New androgen receptor genomic targets show an interaction with the ETS1 transcription factor","volume":"8","author":"Massie","year":"2007","journal-title":"EMBO Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1073\/pnas.182376299","article-title":"The program of androgen-responsive genes in neoplastic prostate epithelium","volume":"99","author":"Nelson","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0168760","DOI":"10.1371\/journal.pone.0168760","article-title":"MicroRNA and transcription factor gene regulatory network analysis reveals key regulatory elements associated with prostate cancer progression","volume":"11","author":"Sadeghi","year":"2016","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"EMBO J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1158\/0008-5472.CAN-10-2581","article-title":"CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells","volume":"71","author":"Frigo","year":"2011","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/edrv-14-1-40","article-title":"Regulation of the cell cycle by calcium and calmodulin","volume":"14","author":"Lu","year":"1993","journal-title":"Endocr Rev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4020-6191-2_7","article-title":"Physiological roles of the Ca2+\/CaM-dependent protein kinase cascade in health and disease","volume":"45","author":"Colomer","year":"2007","journal-title":"Subcell Biochem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev.pharmtox.41.1.471","article-title":"Ca2+\/CaM-dependent kinases: from activation to function","volume":"41","author":"Hook","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"31658","DOI":"10.1074\/jbc.R112.356485","article-title":"Calcium\/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology","volume":"287","author":"Racioppi","year":"2012","journal-title":"J Biol Chem"},{"key":"B92","doi-asserted-by":"publisher","first-page":"28066","DOI":"10.1074\/jbc.M111.251504","article-title":"Ca2+\/calmodulin-dependent protein kinase kinase {beta} is regulated by multisite phosphorylation","volume":"286","author":"Green","year":"2011","journal-title":"J Biol Chem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1021\/bi201005g","article-title":"Generation of autonomous activity of Ca(2+)\/calmodulin-dependent protein kinase kinase beta by autophosphorylation","volume":"50","author":"Tokumitsu","year":"2011","journal-title":"Biochemistry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","article-title":"Hypothalamic CaMKK2 contributes to the regulation of energy balance","volume":"7","author":"Anderson","year":"2008","journal-title":"Cell Metab"},{"key":"B95","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molcel.2006.12.009","article-title":"Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2","volume":"25","author":"H\u00f8yer-Hansen","year":"2007","journal-title":"Mol Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/me.2011-1299","article-title":"Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse","volume":"26","author":"Anderson","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1210\/en.2011-1107","article-title":"The Ca2+\/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation","volume":"152","author":"Lin","year":"2011","journal-title":"Endocrinology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/jbmr.1890","article-title":"Inhibition of Ca(2)(+)\/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation","volume":"28","author":"Cary","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bone.2015.01.021","article-title":"Inhibition of CaMKK2 reverses age-associated decline in bone mass","volume":"75","author":"Pritchard","year":"2015","journal-title":"Bone"},{"key":"B101","doi-asserted-by":"publisher","first-page":"11579","DOI":"10.1074\/jbc.M111.336032","article-title":"Calcium\/calmodulin-dependent protein kinase kinase 2 regulates macrophage-mediated inflammatory responses","volume":"287","author":"Racioppi","year":"2012","journal-title":"J Biol Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/jbmr.3379","article-title":"Inhibition of CaMKK2 enhances fracture healing by stimulating Indian hedgehog signaling and accelerating endochondral ossification","volume":"33","author":"Williams","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/hep.27832","article-title":"The camKK2\/camKIV relay is an essential regulator of hepatic cancer","volume":"62","author":"Lin","year":"2015","journal-title":"Hepatology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molmed.2012.12.004","article-title":"CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem","volume":"19","author":"Racioppi","year":"2013","journal-title":"Trends Mol Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"11793","DOI":"10.1038\/s41598-017-12139-3","article-title":"Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD","volume":"7","author":"York","year":"2017","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"24832","DOI":"10.1074\/jbc.M112.370783","article-title":"A regulatory feedback loop between Ca2+\/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression","volume":"287","author":"Karacosta","year":"2012","journal-title":"J Biol Chem"},{"key":"B107","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/pros.23121","article-title":"Nucleoporin 62 and Ca(2+)\/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells","volume":"76","author":"Karacosta","year":"2016","journal-title":"Prostate"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/pros.22533","article-title":"Down-regulation of calcium\/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer","volume":"72","author":"Shima","year":"2012","journal-title":"Prostate"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.11.023","article-title":"Beyond the vicious cycle: the role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis","author":"Owen","year":"2017","journal-title":"Mol Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI92466","article-title":"Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone","volume":"128","author":"Roca","year":"2018","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.tem.2016.06.001","article-title":"The Ca(2+)\/calmodulin\/CaMKK2 axis: nature\u2019s metabolic CaMshaft","volume":"27","author":"Marcelo","year":"2016","journal-title":"Trends Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T04:15:42Z","timestamp":1529295342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":111,"alternative-id":["10.3389\/fendo.2018.00335"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00335","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"article-number":"335"}}